Johnson & Johnson's Ottava Robotic Surgical System Receives US FDA De Novo Authorization
Johnson & Johnson receives US FDA De Novo authorization for the Ottava Robotic Surgical System, the world's first table-integrated soft tissue robotic platform, expanding access to robotic-assisted surgery across multiple general surgery procedures.
Commercial Rollout | 24/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy